MPM Capital news from FierceBiotech
News
VC: Alder raises $40M
Alder raises $40M VENTURE CAPITALCOMPANY AMOUNT/ROUNDLEAD INVESTORSDESCRIPTIONAlder BiopharmaceuticalsBothell, WA$40MThirdDelphi Ventures and Read more...
PeptImmune land $8.2M in series D
Cambridge, MA-based PeptImmune has garnered $8.2 million in a fourth round of funding. New Enterprise Associates, MPM Capital, Hunt Ventures L.P., Boston Medical Investors and Silicon Valley Bank Read more...
SPOTLIGHT: Xanodyne files IPO
After garnering a total of $232 million in venture funds to buy aaiPharma's pharmaceutical division out of bankruptcy, Xanodyne Pharmaceuticals--which has three products in development in addition Read more...
Seattle start-up gains $30M in second venture round
Another biotech graduate of the Seattle incubator Accelerator Corp. has won a significant round of venture backing. Allozyne says that it has garnered a $30 million Series B, enough money to take a Read more...
VC: Neuromed lands $53.3M in fifth round
Neuromed lands $53.3M in fifth round VENTURE CAPITALCOMPANY AMOUNT/ROUNDLEAD INVESTORSDESCRIPTIONNeuromed Read more...
Neuromed banks $53.3M in venture funds
Neuromed Pharmaceuticals has garnered a whopping $53.3 million in Series E funds, bringing its total take in venture capital to $126 million. Much of that money is earmarked for clinical trials, Read more...
KaloBios gains $20M in third round
KaloBios Pharmaceuticals has garnered $20 million in its third round, with much of that earmarked to advance its clinical development work. Lehman Brothers led the round with MPM Capital, Sofinnova Read more...
VC: Kalypsys gains $100M in third round
Kalypsys gains $100M in third round
Press Release: Elixir Pharmaceuticals Raises $46 Million
Press Release: Elixir Pharmaceuticals Raises $46 Million
Read more...VC: Santaris leads with a $48.3M round
Santaris leads with a $48.3M round
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends